Physicians' Counseling of Adolescents Regarding E-Cigarette Use by Pepper, Jessica K. et al.
Physicians’ Counseling of Adolescents Regarding E-Cigarette 
Use
Jessica K. Pepper, PhDa,b, Melissa B. Gilkey, PhDc, and Noel T. Brewer, PhDa,b
Jessica K. Pepper: pepper@unc.edu; Melissa B. Gilkey: gilkey@email.unc.edu; Noel T. Brewer: ntb@unc.edu
aLineberger Comprehensive Cancer Center, University of North Carolina, 101 Manning Drive, 
Chapel Hill, NC 27514, USA
bDepartment of Health Behavior, Gillings School of Global Public Health, University of North 
Carolina, 324 Rosenau Hall CB #7440, Chapel Hill, NC 27599, USA
cDepartment of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care 
Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA
Abstract
Purpose—Electronic cigarette (e-cigarette) use now surpasses use of conventional cigarettes 
among U.S. adolescents. Given the important role of physicians in preventing adolescent risk 
behaviors, we sought to understand how physicians communicate about e-cigarettes when 
counseling adolescent patients and their parents. We also explored physicians’ support for 
regulations aimed at discouraging adolescents’ e-cigarette use.
Methods—A national U.S. sample of 776 pediatricians and family medicine physicians who 
provide primary care to adolescent patients completed an online survey in spring 2014.
Results—Many physicians (41%) would, if asked, tell their patients that e-cigarettes are less 
harmful than cigarettes, and a substantial minority (24%) would recommend e-cigarettes to 
adolescents for smoking cessation. Most physicians reported routinely screening adolescent 
patients for cigarette smoking but few routinely screened for e-cigarette use (86% vs. 14%, p<.
001). Routine counseling was similarly more common for avoiding cigarette smoking than for 
avoiding e-cigarette use (79% vs. 18%, p<.001). Support for government regulation of e-cigarettes 
was high, with 91% of physicians endorsing policies that prevent minors from buying e-cigarettes.
Conclusions—Physicians infrequently screen or counsel their adolescent patients about e-
cigarette use, even though e-cigarettes often come up during visits. Additional efforts by 
physicians could help prevent future use by adolescents. Recommending e-cigarettes as a smoking 
cessation aid to adolescent patients is inadvisable given the lack of evidence for efficacy in that 
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population. As federal regulation of e-cigarettes remains in limbo, pediatricians and family 
medicine physicians can offer a powerful voice for informing regulations aimed at reducing use by 
adolescents.
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Adolescents’ use of electronic cigarettes (e-cigarettes) is a growing public health concern. E-
cigarettes are battery-powered devices that heat a solution of e-liquid (typically containing 
humectants, flavorings, and nicotine) into an inhalable aerosol. Adolescents’ use of e-
cigarettes, which are also called vapes, vape pens, and mods, has increased dramatically 
since their introduction in the U.S. marketplace in 2007.[1–3] E-cigarette use tripled among 
middle and high school students from 2013–2014, and more students reported using e-
cigarettes in the past 30 days than conventional cigarettes.[3] E-cigarettes pose a risk to 
adolescent health for multiple reasons. E-cigarette use may act as a gateway to smoking 
conventional cigarettes,[1] although studies have yet to conclusively demonstrate such a 
finding. However, recent increases in rates of use of e-cigarettes by adolescents occurred 
simultaneously as decreases in rates of conventional cigarette smoking, allowing for the 
possibility that e-cigarettes could be a pathway from or substitute for tobacco smoking.[3] 
Nonetheless, most e-liquid and e-cigarette aerosol contains nicotine,[4] which is addictive. 
Although research with adults suggests that e-cigarettes may be less addictive than 
cigarettes,[5, 6] no studies have examined the addictive potential of e-cigarettes among 
youth, who have heightened sensitivity to nicotine.[7] Exposure to nicotine can alter the 
structure and function of the developing brains of adolescents [8, 9] and harm fetal 
development should adolescents be using e-cigarettes during pregnancy.[10] If ingested or 
spilled on the skin, e-liquid containing high concentrations of nicotine can be toxic.[11] 
Finally, e-cigarette aerosol contains harmful chemicals like formaldehyde and acetaldehyde.
[12] Thus, while e-cigarettes are likely less harmful than conventional tobacco cigarettes,
[13, 14] their use is not completely safe.[15] Unfortunately e-cigarettes are not currently 
subject to federal regulation, although the U.S. Food and Drug Administration (FDA) has 
proposed a set of regulations including a nationwide ban on sales to minors.[16]
Health care providers are well positioned to intervene to prevent or reduce adolescents’ use 
of e-cigarettes, as they do with other adolescent risk behaviors.[17] Organizations like the 
American Academy of Pediatrics (AAP) have guidelines on best practices for preventing 
and treating tobacco use.[18] The AAP’s “Bright Futures” guidelines suggest using the five 
As approach, adding a sixth A for younger patients: anticipate (future use among younger 
patients), ask (about current use), advise (about the dangers), assess (willingness to change), 
assist (with cessation efforts), and arrange (for follow-up to check on progress). 
Unfortunately, not all physicians include these components (e.g., more physicians “advise” 
than “assist”), and prevention efforts are particularly lacking for younger adolescents.[19] 
When implemented, primary care-based interventions for children and adolescents can be 
effective for preventing and treating adolescent tobacco use.[20] However, little is known 
about how providers incorporate the topic of novel tobacco products like e-cigarettes into 
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preventive care visits with adolescents. Prior studies suggest that health care providers 
regularly discuss e-cigarettes with adolescent and adult patients [21–23] and the frequency 
of patient inquiries is increasing,[23] but most providers feel they lack sufficient knowledge 
about the product and express interest in learning more.[21, 24] To our knowledge, this is 
the first study to explore the topic among a national sample of physicians who treat 
adolescents. Our study aimed to explore physicians’ perceptions of the health harms of e-
cigarettes, beliefs about using e-cigarettes for smoking cessation, as well as their strategies 
for counseling adolescent patients about e-cigarettes. Finally, given that federal regulation of 




We conducted an online survey of pediatricians and family physicians (the specialties 
responsible for most adolescent primary care) in spring 2014. The survey focused on 
administration of adolescent vaccines but also included questions about beliefs and 
behaviors relevant to other preventive care services, including prevention of tobacco and e-
cigarette use. Respondents were members of an existing national panel of physicians that 
was initially constructed from American Medical Association lists and maintained by a 
survey research company. Physicians were eligible to participate if they resided in the U.S., 
spoke English, specialized in pediatrics or family medicine, and provided routine primary 
care to young adolescent patients (ages 11–12).
The survey research company sent invitations via email to 2,368 physician panel members 
with pediatric or family medicine specialties, and 1,022 (43%) physicians opened the 
invitations and visited the survey website. Of these, 776 (76%) were eligible and completed 
the survey. Data on the percentage of ineligible respondents are not available, but overall, 
33% of physicians in the panel completed the survey. Respondents provided informed 
consent online and received up to $45 for their participation. The Institutional Review Board 
at the University of North Carolina approved the study protocol.
Measures
Respondents first viewed images and a brief description of e-cigarettes. If they reported ever 
having talked about e-cigarettes during an adolescent visit, the survey assessed who 
typically raised the topic (the adolescent, the parent, the physician, or someone else) as well 
as the topics discussed. The survey also assessed respondents’ main concerns about e-
cigarettes and which e-cigarette topics they would like to learn more about. For items on e-
cigarette topics and concerns, the survey used closed-ended response options including the 
potential health harms of using e-cigarettes, the potential health harms of breathing 
secondhand e-cigarette aerosol, whether using e-cigarettes helps smokers quit, and whether 
using e-cigarettes leads to smoking.
To understand attitudes about e-cigarettes as a possible tool for smoking cessation or harm 
reduction, we asked participants to indicate agreement (response scale ranged from 
“strongly disagree” (coded as 1) to “strongly agree” (coded as 5)) with these statements: “I 
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would recommend adolescent smokers use e-cigarettes to quit smoking”; “I would 
recommend adult smokers use e-cigarettes to quit smoking”; and “If asked by adolescents or 
their parents, I would say that e-cigarettes are less harmful than regular cigarettes.” In 
addition, participants indicated their agreement (same scale as above) with 4 possible 
regulations that would ban flavored e-cigarettes, ban advertisements targeting youth, prevent 
minors from purchasing, and prohibit e-cigarette use in places where smoking is not 
allowed. For the statement about willingness to recommend e-cigarettes to adolescents for 
smoking cessation and for the policy support variables, we recoded the variable such that a 
value of 0 indicated “strongly disagree,” “somewhat disagree,” or “neither disagree or 
agree,” and 1 indicated “strongly agree” or “somewhat agree.”
The survey assessed routine screening and counseling practices with the items “How often 
do you ask adolescents whether they [use e-cigarettes/smoke regular cigarettes]?” and “How 
often do you counsel non-smoking adolescents about avoiding [e-cigarette use/smoking 
regular cigarettes]?”. We dichotomized these variables such that a value of 0 indicated 
“never,” “rarely,” or “sometimes” and 1 indicated “often” or “always.” We also combined 
the variables regarding screening and counseling to create a single, composite variable 
representing the physician’s efforts at cigarette smoking prevention and e-cigarette use 
prevention. For these variables a value of 1 indicated that the physician “often” or “always” 
screened for use, counseled about use, or both. All other response combinations received a 
score of 0.
Finally, the survey included items assessing characteristics of the respondent (e.g., sex, 
clinical specialty) and their medical practice (e.g., number of adolescent patients seen per 
week). The survey also included a measure of the extent to which physicians follow 
guidelines for appropriate recommendation of HPV vaccine. We chose this indicator 
because of its similarities with prevention efforts for tobacco smoking: both activities 
(counseling on tobacco and recommending HPV vaccine) are explicitly mentioned in 
existing practice guidelines and both are intended to prevent cancer. We classified 
physicians who stated that they recommended HPV vaccine by age 12 for both boys and 
girls as “following vaccine recommendations” (coded 1) and all other physicians as “not 
following vaccine recommendations” (coded 0).
To refine the survey items and ensure that physicians understood the wording as we 
intended, we conducted cognitive interviews with 9 physicians. The survey company also 
pilot tested the survey with 60 physicians who were recruited in the same manner as the 
main sample.
Analysis
We used McNemar’s chi square analysis to compare the proportion of physicians who 
agreed that they would recommend e-cigarettes as a cessation tool to adults versus 
adolescents. We also used McNemar’s chi-square to compare the proportion of respondents 
who engaged in routine screening for cigarette smoking versus e-cigarette use and routine 
counseling for cigarette smoking versus e-cigarette use. Finally, we examined demographic, 
behavioral, and belief variables as potential correlates of three variables: willingness to 
recommend e-cigarettes to help adolescents quit smoking and the two composite measures 
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of cigarette smoking prevention and e-cigarette use prevention (i.e., routinely screening, 
counseling, or both). We used bivariate logistic regressions and then included variables with 
statistically significant (p<.05) bivariate relationships in a simultaneous multivariate logistic 
regression model. We conducted the analyses using Stata Version 12. All statistical tests 
were two-tailed with a critical alpha of .05.
Results
Of the 776 participating physicians, 53% were pediatricians, and 47% were family medicine 
physicians (Table 1). Most physicians were male (68%), in private practice (85%), and 
worked in multi-physician practices (37% worked in practices with 2–4 physicians and 49% 
in practices with 5 or more physicians). About half had been in practice for at least 20 years 
(55%). Most physicians saw at least 10 adolescent patients per week (45% saw 10–24 
patients, and 38% saw 25 or more).
E-Cigarette Attitudes and Beliefs
Concerns and Need for Information—Physicians’ primary concern about e-cigarettes 
was most often the potential health harms of use (50%) and that using e-cigarettes may lead 
to smoking (35%) (Figure 1). Many fewer physicians indicated that their primary concern 
was that e-cigarettes would not help smokers quit (7%), breathing secondhand aerosol might 
be harmful (5%), or that they had no concerns (3%). Most physicians (89%) wanted to learn 
more information about at least one e-cigarette topic. The most popular topic for desired 
education was the potential health harms of use (75%), followed by the potential health 
harms of secondhand aerosol (55%), whether e-cigarettes help smokers quit (55%), and 
whether using e-cigarettes leads to smoking (53%).
Cessation and Harm—Many physicians (40%) agreed that, if asked, they would tell 
adults or adolescents that e-cigarettes are less harmful than cigarettes. A substantial minority 
of physicians agreed that they would recommend e-cigarettes for smoking cessation, 
although endorsement varied by patients’ age (36% would recommend to adults vs. 24% 
would recommend to adolescents, p<.001). In both bivariate and multivariate analyses, 
willingness to recommend e-cigarettes to adolescent patients was associated with beliefs 
about the harm of e-cigarettes and following vaccination recommendations. Physicians who 
agreed with the statement that e-cigarettes were less harmful than cigarettes were more 
likely to be willing to recommend them to adolescents for smoking cessation (35% vs. 17%, 
adjusted OR 2.63, 95% CI 1.88, 3.70). Physicians who followed guidelines for vaccination 
were less likely to be willing to recommend (21% vs. 30%, adjusted OR 0.68, 95% CI 0.48, 
0.96). No other variables were associated with willingness to recommend e-cigarettes to 
adolescents for quitting smoking.
E-Cigarettes in the Clinical Encounter
Discussion of E-Cigarettes—One-third of physicians (34%) reported having ever 
discussed e-cigarettes during an adolescent’s visit. Of those, the physician was the most 
likely to initiate the conversation (46%), followed by the parent (30%), the adolescent 
(23%), or someone else (2%). The most frequent topics of conversation were the potential 
Pepper et al. Page 5













health harms of using e-cigarettes (77%) and not starting to use e-cigarettes (65%). Fewer 
physicians reported discussing whether e-cigarette use helps smokers quit (49%), whether 
using e-cigarettes leads to smoking (42%), the potential health harms of breathing 
secondhand aerosol (41%), or other topics (5%).
Screening and Counseling—Many fewer physicians routinely screened for e-cigarette 
use than cigarette smoking (14% vs. 86% often or always screened, p<.001) (Figure 2). 
Routine counseling about avoiding e-cigarette use compared to cigarette smoking followed 
the same pattern (18% often or always counseled about e-cigarettes vs. 79% for cigarettes, 
p<.001).
In bivariate analyses, e-cigarette use prevention efforts correlated with specialty and number 
of physicians in the practice, but only specialty retained statistical significance in the 
multivariate model (Table 2). Family medicine physicians had higher odds of engaging in 
prevention of e-cigarette use than pediatricians (26% vs. 18%, adjusted OR 1.57, 95% CI 
1.10, 2.25).
Cigarette smoking prevention efforts were associated with region, number of physicians in 
the practice, and following vaccination recommendations in bivariate analyses, but only 
region and following vaccination recommendations were statistically significant in the 
multivariate model (Table 3). Physicians in the South had lower odds of engaging in 
prevention for cigarette smoking than those in the Northeast (87% vs. 95 %, adjusted OR 
0.38, 95% CI 0.18, 0.79), as were physicians in the West (88%, adjusted OR 0.40, 95% 0.18, 
0.91). Physicians who followed federal guidelines for HPV vaccination had higher odds of 
attempting to prevent cigarette smoking than those who did not (93% vs. 86%, adjusted OR 
2.12, 95% 1.31, 3.43).
Support for Regulation of E-Cigarettes
Most physicians supported regulation of e-cigarettes. The majority agreed that e-cigarette 
use should be prohibited where smoking is prohibited (81%) and supported laws banning 
flavors for e-cigarettes (68%). Nearly all respondents also agreed that laws should prevent 
minors from buying e-cigarettes (91%) and advertisements targeting youth should be banned 
(86%).
Discussion
Pediatricians and family medicine physicians are concerned about the health effects of e-
cigarettes, interested in learning more about the topic, and supportive of regulatory action to 
prevent e-cigarette use among youth. Physicians are also initiating and engaging in 
discussions about e-cigarettes with their adolescent patients and their families. However, 
vastly fewer physicians routinely screen and counsel for e-cigarette use than for cigarette 
smoking, which may reflect the novelty of the problem, the lack of practice guidelines, or 
the belief that e-cigarettes are less harmful than conventional cigarettes. Although e-
cigarette aerosol contains fewer carcinogens and harmful constituents than cigarette smoke,
[25] the product is too new to understand whether exposure is linked to long-term, serious 
health consequences. Moreover, e-cigarettes can expose both users [4] and non-users [26] to 
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nicotine, a chemical that impacts adolescent brain development [8, 9] and can be toxic at 
very high concentrations like those present in vials of e-liquid.[11] Thus, regardless of the 
comparative harm of e-cigarettes versus cigarettes, routine screening and counseling for e-
cigarettes may benefit pediatric patients, particularly in light of increasing use among 
adolescents.[1–3]
Family medicine physicians were more likely than pediatricians to try to prevent patients 
from using e-cigarettes. This finding is in line with the results of our previous study of 
providers who treat adolescent patients. In that study, family medicine physicians were more 
likely to be aware of e-cigarettes and reported greater perceived knowledge of and comfort 
discussing e-cigarettes than pediatricians or nurse practitioners.[21] Unlike pediatricians, 
family medicine physicians treat adult patients, and many adults ask their providers about e-
cigarettes.[22, 23] Thus family medicine physicians may be more aware of the health issues 
surrounding e-cigarette use and more likely to screen or counsel their adolescent patients as 
a result. In general, family medicine physicians and pediatricians do not engage in smoking 
cessation efforts with adolescent patients in the same way.[19, 27, 28] For example, 
compared to pediatricians, family medicine physicians are more likely to assess adolescents’ 
motivation to quit smoking, provide quit resources, and screen for use of smokeless tobacco 
(another “alternative tobacco product” like e-cigarettes).[27]
Physicians who followed practice guidelines relevant to one area of cancer prevention (i.e., 
HPV vaccination) were more likely to follow practice guidelines for another type of cancer 
prevention (i.e., cigarette smoking). In contrast, following vaccination guidelines was not 
related to delivery of e-cigarette use prevention efforts, perhaps because such efforts have 
yet to be codified in guidelines including Bright Futures.[18] This finding suggests that, 
should e-cigarettes be incorporated into practice guidelines in the future as conventional 
cigarettes currently are, more physicians might screen or counsel for adolescents’ use.
Despite lower rates of screening and counseling than for conventional cigarettes, e-cigarettes 
are already part of physicians’ clinical encounters with adolescents, as they are with adults.
[22, 23] One-third of respondents in this study reported discussing e-cigarettes with 
adolescent patients, but the data suggest that e-cigarettes come up in conversation more 
frequently than that: less than half of physician respondents said they “never” asked about 
(38%) or “never” counseled on avoiding (39%) e-cigarettes. Thus our results might 
underestimate the prevalence of talking about e-cigarettes if physicians interpreted the item 
about “discussion” to mean only in-depth discussion.
Unfortunately, such discussions might include physicians’ recommending e-cigarettes to 
adolescents for smoking cessation. Although some promising evidence suggests e-cigarettes 
may aid cessation for adults [29] and a substantial minority of health care providers are 
recommending e-cigarettes to adult patients for this purpose,[22, 23] adolescents respond 
differently to smoking cessation interventions than do adults [30] and no randomized 
controlled trials have tested whether e-cigarettes help adolescents quit smoking. Physicians 
who followed vaccination guidelines were less likely to say that they would recommend e-
cigarettes to adolescents as a tool for smoking cessation, perhaps because they were more 
aware that the data on the utility of e-cigarettes for smoking cessation is inconsistent and the 
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FDA has not approved them as a cessation aid. In a random sample of physicians in North 
Carolina in 2013, more than 10% mistakenly believed that the FDA had already approved e-
cigarettes for smoking cessation;[22] this belief might have influenced the almost one-
quarter of physicians who would recommend them to adolescent patients trying to quit 
smoking. Some physicians who would recommend e-cigarettes to adolescents trying to quit 
smoking might also be aware nicotine replacement therapies (NRTs) are not as helpful for 
youth as they are for adults.[30] Physicians who were aware of this finding or had 
previously experienced the failure of NRTs to help their adolescent patients may have been 
eager to find other, newly available options.
Physicians in this study were largely supportive of possible regulations that could limit 
youth access to and appeal of e-cigarettes. Physicians who are especially concerned may be 
interested in advocating for their views. The field of pediatrics has a long history of 
advocacy.[31] For example, the American Academy of Pediatrics (AAP) played a critical 
role in the passage of the State Child Health Insurance Plan, a program that resulted in 
health care coverage for millions of children and adolescents.[31] Previous advocacy 
strategies used by interested physicians include writing letters to the editors of journals of 
newspapers, joining coalitions of community members, and drafting issue briefs for 
lawmakers.
Most family medicine physicians and pediatricians in our study were interested in learning 
more about e-cigarettes. There are some physician-specific resources on this topic, such as 
an AAP handout,[32] but they are limited in scope. Designing appropriate educational 
materials is challenging given that the science surrounding e-cigarettes is evolving so 
rapidly. However, certain established, basic information about e-cigarettes would be useful 
to clinicians who treat adolescents. For example, given physicians’ specific interest in 
learning more about health effects, materials should describe the effects of possible nicotine 
exposure from e-cigarettes and the presence of harmful chemical constituents in some 
samples of e-liquid and aerosol. This type of education may help discourage physicians from 
recommending e-cigarettes, an unproven cessation tool among youth, to adolescents for 
quitting smoking.
Limitations to this study include not surveying nurse practitioners or physician assistants 
who provide primary care to adolescents and not asking about physicians’ prior clinical 
experiences with e-cigarettes (e.g., whether they had patients who used e-cigarettes to quit 
smoking or who experienced harm from e-cigarettes). Also, our definition and images of e-
cigarettes presented at the beginning of the study better represented older models of e-
cigarettes than newer models (e.g., tank systems, mods). Use of the American Medical 
Association master list for recruitment may have limited our sample as not all physicians on 
that list have an email address on record. Although the response rate was relatively low for a 
physician sample, this study was the first to capture a national sample of healthcare 
providers who treat pediatric patients.
Ultimately, understanding what health care providers believe and how they interact with 
patients about e-cigarettes is important because providers play a critical role in preventing 
adolescent risk behaviors including tobacco use.[17] Indeed, even brief counseling from 
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clinicians can reduce adolescents’ risky behaviors.[33] The results of the present study 
suggest a need to improve routine screening and counseling for e-cigarette use among 
adolescents and provide educational resources to physicians. Incorporating e-cigarettes into 
existing practice guidelines about tobacco use could boost prevention efforts and possibly 
prevent recommendation of e-cigarettes as smoking cessation tools for adolescents until 
there is conclusive evidence among youth. Because family medicine physicians and 
pediatricians play a key role in reducing adolescent risk behavior, their efforts, either 
through clinical practice or expressing support for regulation, are crucial for preventing 
further increases in e-cigarette use among youth.
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More adolescents now use e-cigarettes than conventional cigarettes. In this national 
study, many fewer physicians screened or counseled their adolescent patients about use 
of e-cigarettes compared to cigarettes. Enhancing physicians’ abilities and opportunities 
to screen and counsel about e-cigarette use could help prevent adolescents from engaging 
in this risky behavior.
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E-cigarette (EC) topics about which physicians had concerns or wanted more information 
(n=776).
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Physicians’ screening and counseling practices related to cigarettes and e-cigarettes (n=776).
Pepper et al. Page 13

























Pepper et al. Page 14
Table 1




 Male 526 67.8
 Female 250 32.2
Specialty
 Pediatrics 410 52.8
 Family medicine 366 47.2
Years in practice
 Less than 10 years 61 7.9
 10–19 years 291 37.5
 20 or more years 424 54.6
Adolescent patients seen per week
 Less than 10 129 16.6
 10–24 351 45.2
 25 or more 296 38.1
Ever discussed e-cigarettes during adolescent visit
 No 515 66.4
 Yes 261 33.6
Follow HPV vaccination recommendations
 No 311 40.1
 Yes 465 59.9
Practice
Region
 Northeast 184 23.7
 Midwest 165 21.3
 South 275 35.4
 West 152 19.6
Clinic type
 Private practice 660 85.1
 Other 116 15.0
Physicians in practice
 1 physician (solo practice) 115 14.8
 2–4 physicians 283 36.5
 5–9 physicians 217 28.0
 10 or more physicians 161 20.8
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